Atea Pharmaceuticals (AVIR)
Develops oral antiviral candidates for HCV and HEV infections.
$5.73
Pre-market+0.03 (+0.44%)
At close$5.71(+3.92%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
in 69 days
EPS estimate
−$0.51
Revenue estimate
$50.4M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.40−$0.40−$0.44−$0.53−$0.57−$0.57−$0.41Pending
Estimate−$0.35−$0.56−$0.46−$0.46−$0.49−$0.60−$0.56−$0.51
Surprise−14.3%+28.6%+4.3%−15.2%−16.3%+5.0%+26.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————$1.5M$22.4M$33.0M$50.4M
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.51 | — | — |
| Aug 2026 | −$0.56 | −$0.41 | +26.1% |
| May 2026 | −$0.60 | −$0.57 | +5.0% |
| Mar 2026 | −$0.49 | −$0.57 | −16.3% |
| Nov 2025 | −$0.46 | −$0.53 | −15.2% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.51 | — | — | $50.4M | — | — | — |
| Aug 12, 2026 | −$0.56 | −$0.41 | +26.1% | $33.0M | — | — | +0.2% |
| May 12, 2026 | −$0.60 | −$0.57 | +5.0% | $22.4M | — | — | −16.9% |
| Mar 5, 2026 | −$0.49 | −$0.57 | −16.3% | $1.5M | — | — | +11.1% |
| Nov 12, 2025 | −$0.46 | −$0.53 | −15.2% | — | — | — | −12.6% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||||||
| Aug 7, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 6, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 14, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 8, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 10, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 11, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 30, 2021 | |||||||
| Dec 10, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||